



Sickle cell anemia (SCA) is a genetic hemoglobin (Hb) 
disorder characterized by chronic hemolytic anemia and 
recurrent vaso-occlusive events.[1] It is a homozygous, 
monogenic autosomal recessive disorder that occurs as a result 
of a point mutation in the genetic code on chromosome 11, 
in which valine replaces glutamic acid at position six of the 
beta-globin amino acid chain.[2] In conditions of low oxygen 
tension, the abnormal Hb crystallizes and form tactoids 
which deforms the normal red cell shape from biconcave to 
sickle shape.[3] The abnormally shaped and rigid red cells 
are not able to pass through the microvasculature easily, 
resulting in occlusion of small blood vessels with associated 
ischemic‑reperfusion injury, inflammation, and excessive 
production of reactive oxygen radicals including superoxide 
and hydrogen peroxide.[4] Even though patients with SCA 
have the same genetic abnormality, they usually present with 
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unexplained variable clinical manifestations and disease 
severity.
It has been reported that patients with SCA have inefficient 
antioxidant defense system as well as low zinc level.[5,6] 
Antioxidant deficiency leads to chronic oxidative stress which 
play critical function in the development of microvascular 
dysfunction, damage to cellular macromolecules, and 
multiorgan dysfunction.[7] In addition, research has portrayed 
that SCA patients usually have high white blood cell (WBC) 
count and platelet count, which are known to be associated 
with disease severity.[8,9]
Zinc is an essential trace element and the most common 
mineral in the body after iron. It is the only metal that occurs 
in all enzyme classes found in every cell with an important 
role in wound healing, immune system, reproduction, growth, 
blood clotting, smell, vision, taste, proper insulin, and thyroid 
function and has antioxidant properties.[10,11] Zinc has been 
reported to inhibit calcium binding to the membrane of red 
blood cells (RBCs) which is responsible for the formation 
of irreversible sickled RBCs in addition to inhibition of lipid 
peroxidation of cells.[12] This helps to stabilize biomembranes, 
thereby protecting the body against oxidative stress. It is 
believed that the ability of zinc to reduce the vaso‑occlusive 
crisis in SCA is consequent upon these effects.[13] Other 
reported effects of zinc supplementation in SCA include a 
reduction in the incidence of vaso-occlusive crises, reduced 
incidence of infection, enhanced wound healing, and 
growth.[14,15] Several studies have reported low zinc level 
in patients with SCA.[16,17] To the best of our knowledge, no 
published report in the literature had evaluated zinc level 
and its relationship with blood counts among patients with 
SCA in our locality. This study, therefore, aimed to determine 
zinc level in patients with HbSS (SCA) and compare it with 
that of persons with HbAA control as well as to establish 
the relationship between zinc level and some hematological 
parameters in patients with SCA.
MaterIals and Methods
Study area
The study area was Alex Ekwueme Federal University 
Teaching Hospital, Abakaliki, Nigeria, between June 2019 
and March 2020.
Study population
The study population was made up of patients with HbSS 
in steady state aged 18–47 years with age- and sex-matched 
HbAA control.
Study inclusion and exclusion criteria
The following inclusion criteria were used to recruit 
participants into the study – patients with HbSS (SCA) 
confirmed with Hb electrophoresis, patients who have not 
received blood transfusion in the preceding 3 months to the 
study, and those not on hydroxyurea or zinc supplementation, 
absence of febrile illness in the preceding 4 weeks.
While patients who failed to give consent, those with febrile 
illness, history of blood transfusion in the preceding 3 months 
into the study, those on hydroxyurea or zinc, pregnant women, 
and those with HIV or other comorbidities were excluded 
from the study.
Study design
This was a cross-sectional comparative study involving patients 
with HbSS in steady state and HbAA controls (confirmed with 
Hb electrophoresis in alkaline medium).
Steady state was defined as a period without any acute illness, 
pain, and infection for at least 4 weeks before recruitment and 
no blood transfusion in the preceding 3 months.
Data collection methods
Patients were recruited consecutively from the sickle cell 
clinic of Alex Ekwueme Federal University Teaching Hospital, 
Abakaliki. Age- and sex-matched controls with HbAA were 
recruited from among medical students and staff.
Information on sociodemographic characteristics (including 
age, sex, date of last crisis, blood transfusion history, and 
comorbidities) and clinical status were obtained using 
semi-structured interviewer-administered questionnaire and 
review of medical records.
The skin overlying any prominent vein at the antecubital 
region or dorsum of the hand was thoroughly circularly 
cleaned with methylated spirit and allowed to air dry. Four 
milliliters of blood was collected using size 21G needle 
with an attached syringe. Dry cotton wool was placed at 
the site of blood collection, and gentle pressure was applied 
until the bleeding stopped. 2.5 ml of blood was dispensed 
into ethylenediaminetetraacetic acid (EDTA) bottle and the 
remaining 1.5 ml of blood into a plain bottle and allowed to 
stand for 2 h at room temperature to clot and subsequently 
centrifuged at 3000 g for 5 min using the universal benchtop 
centrifuge model 80-2 (Gallenkomp, England). The serum 
extracted was transferred to another plain bottle and stored 
at −20°C freezer till thawed at room temperature and analyzed 
for zinc level using a spectrophotometer (Spectrumlab 752s, 
Gallenkomp, England) and zinc reagent kit supplied by 
Centronic GmbH Wartenberg, Germany. Blood in EDTA 
bottle was used for the analysis of Hb phenotypes using Hb 
electrophoresis by cellulose acetate method in an alkaline 
medium and for the analysis of full blood count using 
hematology analyzer BC‑2800 (manufactured by Shenzhen 
Mindray Bio-Medical Electronic Co. Ltd, Germany). Each 
blood sample collected was well mixed, applied to the 
machine, and approximately, 20ul of blood was aspirated 
and analyzed.
Data analysis
Data collected were analyzed with SPSS software 
version 20 (SPSS Chicago Inc., IL, USA). Percentages, 
proportions, means, and standard deviation were computed 
with descriptive statistics. Association between the mean values 
of zinc and blood counts was explored using Pearson’s linear 
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regression for bivariate correlation. Statistical significance was 
established when probability, P < 0.05.
Ethical consideration
Ethical approval for this study was gotten from the Research and 
Ethics Committee of Ebonyi State University as well as that of 
Alex Ekwueme Federal University Teaching Hospital, Abakaliki. 
Each enrolled participant gave informed written consent.
results
Sixty participants were recruited and were made up of thirty 
SCA (HbSS) patients and thirty sex- and age-matched HbAA 
controls. Among the SCA patients were 17 (56.7%) females 
and 13 (43.3%) males with the mean age of 26.7 ± 7.6 years. 
Majority of them were single, students, and attained secondary 
educational level. The mean age of the control group was 
27.8 ± 5.3 years [Table 1].
Patients with HbSS had significantly lower mean zinc level 
compared to HbAA individuals (P = 0.038). Similarly, patients 
with HbSS had significantly lower Hb level, packed cell 
volume, and RBC count compared to HbAA control (P <0.05). 
On the contrary, patients with HbSS had significantly higher 
white cell count and platelet count compared to HbAA 
individuals [Table 2].
Result of this study also showed that patients with HbSS who 
had severe anemia with Hb value of <7 g/dl had lower zinc 
level than those with Hb value >7 g/dl, though this was not 
significant (χ2 = 0.017, P = 0.8).
Patients with HbSS who had thrombocytosis with platelet count 
of > 400 × 109/l had lower zinc level compared to those who 
do not have thrombocytosis with platelet count of ≤400 × 109/l. 
However, this was not significant (χ2 = 1.655, P = 0.1).
In the same way, a greater proportion of patients with HbSS 
who had leukocytosis with WBC count >11 × 109/l had lower 
zinc level than those with white cell count within the normal 
reference range of 4–11 × 109/l (χ2 = 26.06, P = 0.000).
Correlation between serum zinc level and blood counts 
showed weak positive relationship between zinc level and Hb 
level (r = 0.04, P = 0.8) [Figure 1]. In addition, there was weak 
negative relationship between serum zinc level and platelet 
count (r = −0.3, P = 0.1) [Figure 2], as well as zinc level and 
WBC count (r = −0.2, P = 0.4) [Figure 3].
dIscussIon
Finding from this study showed lower zinc level among 
patients with HbSS (SCA) in steady state compared with 
HbAA control which was significant. This observation is 
consistent with previous reports of reduced zinc levels in 
SCA.[18,19] Despite normal diet, the low zinc level may be 
due to increased hemolysis often associated with SCA which 
releases a considerable amount of zinc into the plasma. This 
is because RBCs are important storage sites for zinc, resulting 
in increased demand and consumption. Increased hemolysis 
results in increased turnover of hemopoietic cells, leading to 
tremendous red marrow expansion. These conditions lead 
to hypermetabolic rate and increase in energy and nutrient 
demand including zinc.[20] Another explanation for low zinc 
level in patients with SCA is elevated zinc loss in urine 
which is likely due to impaired renal tubular reabsorption 
of zinc, presumably due to renal tubular damage due to 
repeated vaso-occlusive events.[21] Hyperzincuria resulting 
from increased hemolysis raises the daily zinc requirement 
significantly in patients with SCA which is not met by the usual 
dietary intake.[21] Furthermore, bone is the main storage site for 
zinc and increased bone degradation in SCA consequent upon 
recurrent bone ischemia, particularly during painful crisis may 
also add to the elevated loss of zinc in urine.[22] Thus, zinc may 
be lost by multiple mechanisms in people with SCA.
This study also found that there was significantly lower Hb 
concentration, packed cell volume, and red cell count among 
patients with SCA in steady state. This finding also agrees 
with the report of previous studies.[17,23] These results were not 
surprising because patients with SCA suffer from continuous 
hemolysis of red cells, with a short survival rate of the RBCs. 
Hence, the Hb values, packed cell volume, and RBC count 
are usually lower than normal healthy (HbAA) individuals. In 
addition, the rate of increase in Hb concentration in response 
to anemia is not proportional to the degree of anemia due to 
blunted response to erythropoietin secretion.[24] The reason 
may be because renal pathology occurs in SCA which may 
affect erythropoietin production.[25] It has been shown that Hb 
S releases oxygen more easily to the tissues compared to Hb A 
Table 1: Sociodemographic features of the participants
Parameter HbSS, n (%) HbAA control, n (%)
Mean age 26.7±7.6 27.8±5.3
Gender
Male 13 (43.3) 14 (46.7)
Female 17 (56.7) 16 (53.3)
Total 30 (100) 30 (100)
Marital status
Single 27 (90) 21 (70)
Married 3 (10) 9 (30)
Total 30 (100) 30 (100)
HbSS: Hemoglobin SS, HbAA: Hemoglobin AA
Table 2: Zinc and hematological parameters among 
patients with hemoglobin SS and hemoglobin AA
Parameter Mean±SD P
HbSS HbAA
Zinc level (ug/dl) 129.3±19.1 134.2±30.3 0.038
Hemoglobin level (g/dl) 7.7±1.8 14.4±1.4 <0.0001
Packed cell volume (%) 23.1±5.2 42.3±4.6 <0.0001
Red blood cell count (×1012/l) 2.9±0.8 4.9±0.5 <0.0001
White blood cell count (×109/l) 13.3±7.3 6.3±1.6 <0.0001
Platelet count (×109/l) 355.1±131 277.2±83.5 0.008
HbSS: Hemoglobin SS, HbAA: Hemoglobin AA, SD: Standard deviation
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and that may explain the reason why individuals with SCA are 
usually stable at lower Hb concentrations compared to those 
with HbAA. On the other hand, raising the packed cell volume 
to over 30% could increase blood viscosity with resultant risk 
of vaso-occlusive crisis and other adverse consequences.
The mean total WBC count among patients with SCA was 
significantly higher than that of HbAA individuals. This is similar 
to findings from previous studies which also reported an increase 
in total white cell count in individuals with SCA.[8,9] This may be 
due to redistribution of WBCs between the marginal and circulating 
pools, which has been reported to be associated with factors such 
as pain, anxiety, and inflammation in the absence of infection.[8] 
Leukocytosis in SCA may also be due to autosplenectomy resulting 
from recurrent splenic vessel occlusion.[26]
This study also found that the overall mean platelet count was 
significantly higher in HbSS participants compared to those of 
HbAA individuals. Reports from previous studies gave similar 
findings.[17,27] In adult sickle cell patients, loss of splenic platelet 
pool consequent upon autosplenectomy may have contributed 
to higher mean platelet count in SCA patients compared to 
HbAA individuals. Besides, thrombocytosis observed in 
SCA may be consequent upon the negative feedback effect of 
erythropoietin production in SCA in response to anemia. About 
half of thrombopoietin structure has similarity to erythropoietin 
at the N-terminal end. Thrombocytosis is therefore known to 
be associated with certain chronic anemias.[28]
This study showed a positive correlation between the serum 
zinc and Hb concentration among patients with SCA, though 
not statistically significant. This conforms with the findings 
of Atasoy and Bugdayci,[29] who reported that low zinc level 
contributed to most of the anemia in children. This observation 
may be due to the chronic hemolytic state associated with 
SCA with resultant loss of zinc from the RBC which is one 
of the storage sites for zinc and its subsequent loss in urine. It 
has been proposed that the role of zinc in the care of patients 
with SCA is through its calcium antagonism. Zinc hinders the 
action of calmodulin which stimulates the calcium-ATPase 
that regulates the calcium pump system of the RBCs. An 
influx of calcium into the RBCs occurs during sickling and 
this may be as a result of overactivation of calmodulin with 
consequent membrane derangement. Therefore, zinc therapy 
produces antisickling effect through its action on calmodulin 
with consequent calcium antagonism.[30]
Furthermore, patients with SCA who had normal platelet 
count had a higher zinc level compared to those who had 
thrombocytosis though not significant. It has been reported 
that increased serum zinc level significantly increases platelet 
reactivity.[31]
Patients with SCA with leukocytosis had lower zinc level 
compared to those with white cell count within the normal 
reference range. This is supported by findings from a previous 
study which reported that dietary zinc deficiency increases the 
number and distribution of WBCs.[32]
conclusIon
Patients with SCA have lower serum zinc level compared to 
HbAA individuals. Low zinc level is associated with lower Hb 
level, higher white cell count as well as higher platelet count.
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Recommendations
Periodic evaluation and supplementation of zinc should be 
considered as part of intervention strategies in the management 
of SCA to reduce complications such as irreversible red cell 
damage, hemolysis, and anemia.
Further studies on a wider scale are needed to confirm the 
effects of zinc supplementation on hematological parameters 
in SCA patients.
Study limitation
The power of this study to detect significant results could have 
been affected by the small sample size.
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